… double digit revenue and normalised earnings before interest, taxes, depreciation, … digit organic revenue and stronger earnings before interest, taxes, depreciation … distribution and promotional agreement with Boehringer Ingelheim for its product portfolio …

After completing an internship at Boehringer Ingelheim in Duluth, Ga., and her … to reaching her goal after earning her Master of Interdisciplinary Studies … the summer, she interned at Boehringer Ingelheim, a pharmaceutical company in Duluth …

… 18.2 forward price-to-earnings ratio, which is lower than … a generic Seroquel XR by Boehringer Ingelheim earlier this week, which would …

… Cognizant Technology Solutions Corporation beats earnings expectations. Reported EPS is $ … Technology Solutions First Quarter 2025 Earnings Conference Call. All lines … in action. With pharmaceutical company, Boehringer Ingelheim, we launched a cloud-based …

… —loom large as Q1 2025 earnings season rolls on, with Pfizer … continuing in Chicago. Merck, GSK, Boehringer Ingelheim, Roche and others have presented …

… reduces cooling requirements by 30%. Boehringer Ingelheim said the laboratories would allow … cancer indications would be researched. Boehringer Ingelheim did not immediately respond to … . In its 2023 full-year earnings release in April this year …

… company's quarterly earnings topped Wall Street estimates, … Montarce said during an earnings call on Thursday. Shares … of analysts by LSEG:  Earnings per share: $5.32 … collaboration with its Jardiance partner Boehringer Ingelheim. The results also kick …

… Photography Boehringer Ingelheim announced an ambitious pipeline strategy Tuesday in its 2023 earnings … board of managing directors at Boehringer Ingelheim, said in a statement. “We …

Boehringer Ingelheim’s 2023 was largely marked … said in its full-year earnings release. The company specifically highlighted …

… s fiscal 2025 third quarter earnings conference call for the … the risks listed in our earnings release and the risk … in today's earnings release and in the supplemental … President, Commercial Strategy Yeah. So Boehringer Ingelheim has been a very long …